EEI also attenuates NASH, which is a progressive form of NAFLD, by reducing lipid accumulation, fatty change, inflammation and increase of AST and ALT enzymes in the liver of rats. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.